|
| |
viral immunotherapy companies Pages on BioPortfolio:
BioPortfolio - Cancer Immunotherapy companies
BioPortfolio - Cancer Immunotherapy companies Recent Search Terms used to find this page: viral immunotherapy companies | Immunotherapy vancouver | us . ...
http://www.bioportfolio.com/search/Cancer_Immunotherapy_comp...
|
BioPortfolio Biotechnology BioNews : live article
Trial results for spi-VECTM oral immunotherapeutic vaccine reported - Hepatitis ... using spi-VECTM technology, targeting a range of chronic viral diseases. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
PowderMed's Therapeutic DNA Vaccine for Chronic Hepatitis B Enters ...
PowderMed is a private immunotherapeutic company based in Oxford, UK. ... responsible for the most common form of parenterally transmitted viral hepatitis
. ...
http://www.bioportfolio.com/biotech_news/PowderMed_7.htm...
|
BioPortfolio Biotechnology BioNews : live article
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, ... factor (DISC-GM-CSF) is an immunotherapy product that uses the DISC-HSV ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
USC Marshall School of Business Announces Six Nominees for ...
PowderMed Limited - a private immunotherapeutic company based in Oxford, UK, ... as well as a treatment of chronic viral diseases and cancer, namely genital ...
http://www.bioportfolio.com/biotech_news/USC_Marshall_1.htm...
|
Biotechnology News Chickenpox harvard. vaccin. adult. virus. bird ...
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, ... Efficacy, dosage concerns unresolved on sublingual immunotherapy ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Drug Delivery in Cancer - technologies, markets and companies ...
These include antiangiogenic agents, immunotherapy, bacterial agents, viral oncolysis, targeting of cyclic-dependent kinases and tyrosine kinase receptors,
...
http://www.bioportfolio.com/cgi-bin/acatalog/Drug_Delivery_i...
|
Australian biotech Virax grants French Transgene technology ...
The Company’s lead product, VIR201, an HIV/AIDS immunotherapeutic ... Transgene has bio-manufacturing production capacities for viral-based vectors and ...
http://www.bioportfolio.com/biotech_news/Virax_6.htm...
|
OXFORD BIOMEDICA TO ACQUIRE OXXON THERAPEUTICS
12 Mar 2007 ... The Company has started Phase III development of its lead cancer immunotherapy product, TroVax, in renal cancer and has an ongoing Phase II ...
http://www.bioportfolio.com/biotech_news/Oxford_BioMedica_34...
|
Powdermed’s PMED “GENE Gun” NAMED TO THE POPULAR SCIENCE®
PowderMed is a private immunotherapeutic company based in Oxford, UK. ... of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer.
...
http://www.bioportfolio.com/biotech_news/PowderMed_3.htm...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - Cancer Immunotherapy companies
BioPortfolio - Cancer Immunotherapy companies Recent Search Terms used to find this page: viral immunotherapy companies | Immunotherapy vancouver | us . ...
http://www.bioportfolio.com/search/Cancer_Immunotherapy_comp...
|
Lipid Sciences, Inc.' Viral Immunotherapy Study Demonstrates ...
Lipid Sciences, Inc. (LIPD)' Viral Immunotherapy Study Demonstrates Promising Results 6/25/2007 ... 2008 BioSpace, Inc - an onTargetjobs company ...
http://www.biospace.com/news_story.aspx?NewsEntityId=61031...
|
T cell costimulatory molecules in anti-viral immunity: Potential ...
Replication-defective adenoviruses, modified canary pox, and other viral vectors are being developed for immunotherapy (68-70). ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=20...
|
Third HDL Selective Delipidation Patent Granted to Lipid Sciences ...
1 Jul 2008 ... The Company's Viral Immunotherapy platform focuses on the removal of the lipid coatings from lipid-enveloped viruses and other ...
http://biz.yahoo.com/iw/080701/0412058.html...
|
From the Beach, the Next Wave: Immunotherapy in HIV Infection
At week 32, the patients showed significant viral load decreases and CD4+ ... The company also plans to look at anti-HIV CTL responses in upcoming studies.
...
http://www.medscape.com/viewarticle/429112...
|
Replikun Biotech to Commercialise a West Nile Virus Vaccine ...
Australian vaccine and immunotherapy company, Replikun Biotech Pty Limited ... This technology may provide a superior alternative to other viral vectors, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=97329...
|
Immunotherapy of malignant diseases: cancer therapy beyond ...
mutant tumour proteins such as CDK4R24C, and viral onco-. Cancer vaccines .... also be obtained in the adoptive immunotherapy of malignant. diseases.
http://www.roche.com/pages/downloads/company/pdf/rtpenzberg0...
|
Research Associate for Cancer Immunotherapy Job, Lab Support, A ...
Research Associate for Cancer Immunotherapy. Lab Support, A Division Of On Assignment ... 2008 BioSpace, Inc - an onTargetjobs company ...
http://www.biospace.com/job_view.aspx?JOB_ID=243989...
|
Cancer immunotherapy: breaking the barriers to harvest the crop ...
The second major barrier that immunotherapy practitioners perceive involves access to agents owned by companies. Many of the interesting agonists and ...
http://www.nature.com/nm/journal/v10/n9/full/nm0904-887.html...
|
Immunotherapy and Gene Therapy Elizabeth Simpson
representatives from biotechnology companies, The. National Blood Service, a patient group ..... vaccine therapy for cancer and chronic viral infections, as
...
http://www.biomedcentral.com/content/pdf/cd-522743.pdf...
|
|
